Wells Fargo & Company MN lessened its stake in shares of LHC Group, Inc. (NASDAQ:LHCG) by 7.2% during the third quarter, HoldingsChannel reports. The firm owned 212,099 shares of the health services provider’s stock after selling 16,387 shares during the period. Wells Fargo & Company MN’s holdings in LHC Group were worth $21,844,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently modified their holdings of LHCG. First Citizens Bank & Trust Co. acquired a new position in shares of LHC Group during the third quarter worth about $204,000. Bank of Montreal Can lifted its stake in shares of LHC Group by 251.9% during the second quarter. Bank of Montreal Can now owns 2,481 shares of the health services provider’s stock worth $212,000 after purchasing an additional 1,776 shares in the last quarter. Raymond James & Associates acquired a new position in shares of LHC Group during the second quarter worth about $243,000. Oppenheimer Asset Management Inc. acquired a new position in shares of LHC Group during the second quarter worth about $245,000. Finally, Oppenheimer & Co. Inc. acquired a new position in shares of LHC Group during the second quarter worth about $264,000. Institutional investors own 86.96% of the company’s stock.
NASDAQ:LHCG opened at $104.87 on Friday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.61 and a current ratio of 1.61. LHC Group, Inc. has a one year low of $58.65 and a one year high of $107.51. The stock has a market capitalization of $3.29 billion, a P/E ratio of 34.54, a price-to-earnings-growth ratio of 1.76 and a beta of 0.80.
LHCG has been the topic of a number of recent research reports. SunTrust Banks boosted their price objective on LHC Group to $115.00 and gave the stock a “buy” rating in a research note on Thursday, September 13th. UBS Group assumed coverage on LHC Group in a research note on Thursday, November 15th. They issued a “buy” rating and a $109.00 price target on the stock. Royal Bank of Canada boosted their price target on LHC Group to $101.00 and gave the stock a “sector perform” rating in a research note on Friday, August 3rd. Jefferies Financial Group boosted their price target on LHC Group to $120.00 and gave the stock a “buy” rating in a research note on Friday, August 3rd. Finally, Zacks Investment Research cut LHC Group from a “buy” rating to a “hold” rating in a research note on Wednesday, November 7th. Four research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $105.92.
In related news, CEO Keith G. Myers sold 75,000 shares of the business’s stock in a transaction dated Tuesday, November 6th. The stock was sold at an average price of $95.10, for a total value of $7,132,500.00. Following the completion of the sale, the chief executive officer now directly owns 200,765 shares of the company’s stock, valued at $19,092,751.50. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, COO Donald Dwayne Stelly sold 2,756 shares of the business’s stock in a transaction dated Friday, September 7th. The shares were sold at an average price of $99.32, for a total value of $273,725.92. Following the completion of the sale, the chief operating officer now directly owns 104,512 shares of the company’s stock, valued at $10,380,131.84. The disclosure for this sale can be found here. Insiders own 6.80% of the company’s stock.
TRADEMARK VIOLATION WARNING: This report was first posted by Community Financial News and is the property of of Community Financial News. If you are reading this report on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The original version of this report can be read at https://www.com-unik.info/2018/12/01/wells-fargo-company-mn-sells-16387-shares-of-lhc-group-inc-lhcg.html.
LHC Group Profile
LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.
Recommended Story: How to Invest in a Bull Market
Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG).
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.